Person profile
Public information reviewedRobert Azelby
Board role
Director · Terns Pharmaceuticals (NASDAQ: TERN)
Board role
Director · ADC Therapeutics SA (NYSE: ADCT)
Terns Pharmaceuticals (NASDAQ: TERN)
Director · Current mandate
Director
- Evidence records
- 6
- Profile ownership
- Not yet claimed
- Record reviewed
- May 15, 2026

